Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05562973

Organisation Name: Johns Hopkins University

Overal Status: Not yet recruiting

Start Date: January 15, 2023

Last Update: November 10, 2022

Lead Sponsor: Johns Hopkins University

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and potential efficacy of psilocybin-assisted psychotherapy to reduce post-traumatic stress disorder (PTSD) severity in a sample of individuals with PTSD.

Conditions:
  • Post-Traumatic Stress Disorder


Total execution time in seconds: 0.30347895622253